Evidence map›Paper›PMID 36363027›Full record

ArticleMaterials (Basel, Switzerland)2022

Influence of rGO on the Crystallization Kinetics, Cytoxicity, and Electrical and Mechanical Properties of Poly (L-lactide-co-ε-caprolactone) Scaffolds.

Esperanza Díaz, Joseba León, Alberto Murillo-Marrodán, Sylvie Ribeiro, Senentxu Lanceros-Méndez

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Poly(ε-caprolactone-RSC advances · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Esperanza DíazEscuela de Ingeniería de Bilbao, Departamento de Ingeniería de Minera, Metalúrgica y Ciencia de Materiales, Universidad del País Vasco (UPV/EHU), 48920 Portugalete, Spain.ORCID 0000-0001-6483-6593
Joseba LeónDepartment of Mechanics, Design and Industrial Management, University of Deusto, Avda Universidades 24, 48007 Bilbao, Spain.
Alberto Murillo-MarrodánDepartment of Mechanics, Design and Industrial Management, University of Deusto, Avda Universidades 24, 48007 Bilbao, Spain.ORCID 0000-0001-8334-2695
Sylvie RibeiroCentro de Física, Universidade do Minho, 4710-058 Braga, Portugal.
Senentxu Lanceros-MéndezBcMaterials, Basque Centre for Materials, Applications and Nanostructures, (UPV/EHU) Science Park, 48940 Leioa, Spain.ORCID 0000-0001-6791-7620
Universidad de Deusto · ESIkerbasque · ESUniversity of Minho · PTUniversity of the Basque Country · ES

Funding

University of the Basque Country Esperanza Díaz
6 · The paper itself

Abstract

Biodegradable scaffolds of poly (L-lactide-co-ε-caprolactone) (PLCL) and reduced graphene oxide (rGO) were prepared by TIPS (thermally induced phase separation). The nonisothermal cold crystallization kinetics were investigated by differential scanning calorimetry (DSC) with various cooling rates. The experimental values indicate that nonisothermal crystallization improves with cooling rate, but the increasing rGO concentration delays crystallization at higher temperatures. The activation energies were calculated by the Kissinger equation; the values were very similar for PLCL and for its compounds with rGO. The electrical conductivity measurements show that the addition of rGO leads to a rapid transition from insulating to conductive scaffolds with a percolation value of ≈0.4

Indexed as

crystallizationcytotoxicityelectrical propertiesmechanical propertiesPLCL/rGOscaffolds

Identifiers

PMID36363027
PMCPMC9658019
OpenAlexW4307269967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.